Is Milestone Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Milestone Pharmaceuticals Inc (MIST) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Milestone Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Milestone Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Milestone Pharmaceuticals Inc?

Muslim investors may consider investing in Milestone Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Milestone Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Milestone Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Milestone Pharmaceuticals Inc updated?

The Shariah compliance status of Milestone Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Milestone Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Milestone Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Milestone Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MIST Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 23, 2026

Report Source: 2025 Annual Report

Milestone Pharmaceuticals Inc. Stock Analysis MIST

United States Health Care Micro Cap Report: 2025 Annual

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. The company is headquartered in Montreal, Quebec and currently employs 38 full-time employees. The company went IPO on 2019-05-09. The firm is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The firm is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.

Key Statistics of Milestone Pharmaceuticals Inc (MIST)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.47$1.61

Today's Open

$1.58

Volume

2.02M

P/E Ratio (TTM)

52 Week Range

$1.00$3.06

Market Cap

221.21M

Avg. Volume

1.64M

Dividend Yield

Financial Metrics & Statements of Milestone Pharmaceuticals Inc (MIST)

FAQ's for Milestone Pharmaceuticals Inc (MIST)

According to Musaffa’s Shariah screening methodology, Milestone Pharmaceuticals Inc (MIST) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.